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Tinea imbricata (TI) is a chronic superficial mycosis 
caused by Trichophyton concentricum. This mycosis 
is characterised by widespread, annular, concentric, 
squamous lesions, often accompanied by pruritus. TI 
is endemic in South-West Pacific, South-East Asia, and 
Central and South America (1–15).
We present a case of TI in an Italian woman who 
acquired the infection after a 3-month trip to Tahiti, 
Samoa and Solomon Islands. To our knowledge, this is 
the 5th case of TI in a visitor to an endemic area.
CASE REPORT
A 47-year-old Italian woman was admitted because of dermatitis 
located on the thighs and legs. The patient stated that she was in 
good general health and that she was not in therapy with systemic 
drugs. Clinical history revealed that the dermatitis appeared 7 
months earlier, just a few days after a 3-month trip to Tahiti, 
Samoa and Solomon Islands. In Tahiti and Samoa the patient had 
sexual intercourse. She also stated that a previous diagnosis of 
contact dermatitis was made at other centres, for which she was 
treated, although unsuccessfully, for 7 months with topical and 
oral corticosteroids and oral antihistamines. 
Dermatological examination revealed dermatitis located on the 
buttocks, thighs and legs. It was characterised by multiple, an-
nular, concentric, erythematous-purpuric lesions (Fig. 1). In ad-
dition, 3 clinically similar lesions were present on the right breast 
and the abdomen. The patient complained of severe pruritus. 
Patch tests were negative. Two biopsies were performed. The 
histopathological examination showed the presence of numerous 
hyphae within the stratum corneum. Direct immunofluores-
cence was negative. Mycological examination showed short, 
septate hyphae and several chlamydospores. Three cultures on 
Sabouraud dextrose agar medium added with chloramphenicol 
and cycloheximide were positive for T. concentricum. No PCR 
amplification study was performed.
All laboratory examinations, including immunological tests, 
were within normal ranges or negative, except for erythrocyte 
sedimentation rate (43 mm at the 1st hour; normal < 25 mm). 
The patient was treated with griseofulvin (1 g/day for 6 weeks) 
and 1% terbinafine cream (2 applications/day for 6 weeks). Al-
most complete remission of the clinical picture was observed 3 
weeks later. However, culture was still positive, but the infection 
was cleared 6 weeks after starting the therapy. Follow-up one 
year later was negative.
It was possible to examine the mother and 2 sisters of the 
patient, but none of them had skin lesions.
DISCUSSION
TI is known by several names, among them Tokelau 
(the most used synonym, from the name of islands in 
the South Pacific where most of the population is af-
fected by the disease) (12, 15). Other popular names 
of TI are bakwa, cacapash, chimberé, Chinese tinea, 
circinate tinea, concentric tinea, elegant tinea, Gilber-
tese disease, gogo, grillé, Hanumarn ringworm, Indian 
tinea, lace tinea, roña, scaly tinea and shishiyotl (12, 
15). 
The dermatophyte T. concentricum (Blanchard 1895) 
presents with short, septate hyphae, numerous chla-
mydospores and no arthroconidia (12, 15). Some strains 
can present with characteristic structures, the so-called 
“favic chandeliers” (15). On Sabouraud dextrose or 
glucose agar or on Sabouraud with cycloheximide and 
chloramphenicol, colonies develop in 8–25 days at 25°C 
(Fig. S11). The underside is amber in colour (12, 15). 
Some strains require the addition of thiamine (12, 15). It 
was hypothesised that 2 strains of T. concentricum exist: 
one which grows at 20–25°C, and one which grows at 
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Fig. 1. Multiple, annular, concentric, erythematous-purpuric lesions on 
the legs.
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28°–30°C; however, this has not been proved yet (12, 
15). Identification of the strains was confirmed by PCR 
amplification and sequencing of the internal transcribed 
spacer-rDNA regions in only one study (14).
TI affects subjects living in isolated and poor areas 
(12, 14, 15). Poor hygiene and overcrowding are con-
sidered as predisposing factors (12, 15). 
Genetic predisposition to TI has been studied. Ac-
cording to some authors (4, 5), an autosomal recessive 
inheritance of susceptibility to TI exists. According to 
other authors (13), the type of inheritance is autosomal 
dominant with incomplete penetrance.
Immunology of patients with TI has also been ex-
tensively studied (6–8). In a study by Hay et al. (6), 
52% of patients had immediate-type hypersensitivity 
or negative responses (46% of patients) to intradermal 
trichophytin. The majority of patients failed to develop 
delayed-type hypersensitivity on skin testing or as as-
sessed by leucocyte migration inhibition. Furthermore, 
78% of patients had antibody to T. concentricum. In 
another study by Hay et al. (8), patients with TI were 
found to have raised immunoglobulin (Ig) levels to T. 
concentricum antigen. IgE class antibodies were raised.
TI is characterised by multiple, annular, concentric, 
squamous lesions, with or without erythema. The 
infection often begins in childhood on the face and 
subsequently involves the trunk and limbs (12, 14, 15). 
Repeated contacts of an infected mother with her child 
is one of the most frequent modality of infection (38). 
Palmo-plantar surfaces and the scalp can be affected, 
al though the pilosebaceous unit is never involved (12, 
15). The forehead, axillae and groin are usually spared. 
Hay et al. (7) proposed 7 different clinical patterns of 
TI: concentric, lamellar, lichenified, plaque-like, an-
nular, palmar/plantar and onychomycosis, to which 
seborrhoea-like lesions on the scalp and hyper-hypo-
chromic lesions have been subsequently added (12, 15). 
The nails are occasionally involved as distal subungual 
onychomycosis (12, 13, 15). Pruritus may be absent 
or mild or severe (12, 14): in the latter case, chronic 
scratching causes lichenification (14). Differential 
diagnosis of TI includes other tineas (due to Epider-
mophyton floccosum, T. mentagrophytes, T. tonsurans 
and Microsporum audouinii), pityriasis versicolor “im-
bricata”, secondary syphilis, yaws, erythema annulare 
centrifugum, sarcoidosis and erythema gyratum repens. 
The clinical course of TI is chronic. Spontaneous im-
provement is very rare (6, 15).
Since the 1950s, TI was treated with griseofulvin 
(2, 9, 12, 15). A study compared the efficacy of gri-
seofulvin, fluconazole, itraconazole and terbinafine. 
Significant remission was achieved in the terbinafine 
and griseofulvin groups. The fluconazole group ex-
perienced no significant remission; and was of short 
duration in the itraconazole group (11). A double-blind, 
randomised, controlled study compared the efficacy of 
terbinafine with itraconazole. Terbinafine was assessed 
as having a superior clinical and mycological cure rate 
after 4 weeks. After 13 weeks of follow-up, terbinafine 
provided a significantly reduced rate of relapse/rein-
fection compared with itraconazole (10). Relapse and 
reinfection are very common (6, 7, 12, 15). Subjects 
belonging to a susceptible population can carry the 
disease for their lifetime (15).
It was stated that people not genetically related to 
specific ethnic groups very rarely acquire the infection, 
even after prolonged and close contact with infected 
persons (15) This statement is true, because the review 
of the literature revealed that TI is exceptionally rare 
in non-natives, but this possibility exists. In fact, from 
1952, at least 4 cases were published. The first patient 
was an English officer of the Malaysian police (1). The 
other cases were an Australian boy who acquired the 
infection in Fiji islands (2); a French soldier who was 
infected in Tahiti (3) and an English nurse who cont-
racted TI in Papua New Guinea (9). It is possible that 
in our patient the infection was contracted because of 
sexual intercourse with natives. The clinical presenta-
tion of TI in our patient was atypical. This was likely 
due to the fact that the patient was treated for a long 
period of time with topical and oral corticosteroids. 
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